cell type (antibody) | intratumoral | peritumoral | |||||
---|---|---|---|---|---|---|---|
 |  | cells / mm2 |  | % of patients | cells / mm2 |  | % of patients |
eosinophils | (EG-2) | Â | n = 159 | Â | Â | n = 140 | Â |
 | none/few | 0-10 |  | 29 | 0-50 |  | 31 |
 | moderate | 11-50 |  | 50 | 51 - 200 |  | 43 |
 | many | > 50 |  | 21 | > 200 |  | 26 |
neutrophils | (elastase) | Â | n = 160 | Â | Â | n = 152 | Â |
 | none/few | 0-5 |  | 21 | 0 - 75 |  | 24 |
 | moderate | 6 - 50 |  | 54 |  |  |  |
 | many | > 50 |  | 25 | > 75 |  | 76 |
mast cells | (tryptase) | Â | n= 160 | Â | Â | n = 151 | Â |
 | none/few | 0 -5 |  | 19 | 0-30 |  | 25 |
 | moderate | 6 -50 |  | 52 | 31 -100 |  | 59 |
 | many | > 50 |  | 29 | > 100 |  | 16 |
macrophages | (CD68) | Â | n = 159 | Â | Â | Â | Â |
 | none/few | 0-50 |  | 28 |  |  |  |
 | moderate | 51 -150 |  | 50 |  |  |  |
 | many | > 150 |  | 22 |  |  |  |
NK cells | (CD56) | Â | n = 159 | Â | Â | n = 136 | Â |
 | none | 0 |  | 33 | 0 |  | 43 |
 | moderate/many | > 0 |  | 67 | > 0 |  | 57 |
T cells | (CD3) | Â | n = 158 | Â | Â | n = 157 | Â |
 | none/few | 0-55 |  | 27 | 0-300 |  | 20 |
 | moderate | 56-105 |  | 36 | 301 - 500 |  | 51 |
 | many | >105 |  | 37 | > 500 |  | 29 |
CD4+ cells | Â | Â | n = 156 | Â | Â | n = 130 | Â |
 | none/few | 0-30 |  | 43 | 0-20 |  | 24 |
 | moderate | 31 -65 |  | 26 | 21 -110 |  | 50 |
 | many | >65 |  | 31 | > 110 |  | 26 |
CD8+ cells | Â | Â | n = 159 | Â | Â | n = 122 | Â |
 | none/few | 0-15 |  | 26 | 0-135 |  | 77 |
 | moderate | 16-75 |  | 47 |  |  |  |
 | many | >75 |  | 27 | > 135 |  | 23 |